Entrada Therapeutics
Jeffrey Grover is a Senior Scientist I at Entrada Therapeutics. At Entrada, Jeffrey led the transcriptomic characterization of a toxicity profile for a new class of therapeutics. Prior to Entrada, Jeffrey worked as a Genomics Scientist at Seven Bridges, where Jeffrey built bioinformatics analysis workflows. Jeffrey also has experience as a Graduate Assistant at the University of Arizona, a Research Associate at MPI Research, and Laboratory Assistant positions at Michigan State University and the University of Notre Dame. Jeffrey holds a Ph.D. in Molecular and Cellular Biology from the University of Arizona.
Entrada Therapeutics
2 followers
Entrada Therapeutics’ mission is to transform the treatment of devastating diseases and improve patients' quality of life by developing intracellular biologics.